Edgewise Therapeutics Inc (EWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 12,822 | 13,076 | 10,460 | 6,857 | 6,344 |
| Operating Income | -12,822 | -13,076 | -10,460 | -6,857 | -6,344 |
| Other Income | 126 | 127 | 107 | 42 | 2 |
| Pre-tax Income | -12,696 | -12,949 | -10,353 | -6,815 | -6,342 |
| Net Income Continuous | -12,696 | -12,949 | -10,353 | -6,815 | -6,342 |
| Net Income | $-12,696 | $-12,949 | $-10,353 | $-6,815 | $-6,342 |
| EPS Basic Total Ops | 3.70 | -0.26 | -0.21 | -4.37 | -4.49 |
| EPS Basic Continuous Ops | 3.70 | -0.26 | -0.21 | -4.37 | -4.47 |
| EPS Diluted Total Ops | 3.70 | -0.26 | -0.21 | -4.37 | -4.49 |
| EPS Diluted Continuous Ops | 3.70 | -0.26 | -0.21 | -4.37 | -4.47 |
| EBITDA(a) | $-12,744 | $-13,012 | $-10,409 | $-6,778 | $-6,294 |